Pub. date: 2008 | Online Pub. Date: May 22, 2008 | DOI: 10.4135/9781848605985 | Print ISBN: 9781847870483 | Online ISBN: 9781848605985| Publisher:SAGE Publications LtdAbout this handbook
Chapter 41: Unlocking the Potential of Biomarkers in Targeted Oncology
Unlocking the potential of biomarkers in targeted oncology In Europe and the United States, close to 20 million people live with cancer today, and approximately 2.6 million new cases are diagnosed each year, a number that is increasing mainly as a result of demographic change, because most types of solid cancer are typically diseases of the elderly. More than 6 million people around the world die of cancer every year, and one of two men and one of three women will develop cancer in their lifetimes. Moreover, cancer is the leading cause of death, after cardiovascular diseases, in the major pharmaceutical markets (United States, France, Germany, Italy, Spain, United Kingdom, and Japan). The overall annual costs associated with malignancies currently amount to $107 billion. According to the American Cancer Society's Cancer Facts & Figures 2003 publication, more than 1.3 million new cases were expected to be diagnosed in the United ...